Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label Study to Evaluate the Efficacy, Tolerability, and Safety of Partially to Fully HLA-Matched Allogeneic Cryopreserved Deceased-Donor Bone Marrow Transplantation and Living Donor Transplantation in Patients With Hematologic Malignancies

NCT07710781 is registered in ClinicalTrials.gov with Ossium Health, Inc. as lead sponsor.

NCT NCT07710781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07710781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label Study to Evaluate the Efficacy, Tolerability, and Safety of Partially to Fully HLA-Matched Allogeneic Cryopreserved Deceased-Donor Bone Marrow Transplantation and Living Donor Transplantation in Patients With Hematologic Malignancies
Lead sponsor
Ossium Health, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
March 31, 2031
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute biphenotypic leukemia, acute leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, acute undifferentiated leukemia, chronic myeloid leukemia, cll (chronic lymphocytic leukemia), cutaneous t cell lymphomas (ctcl), hematologic malignancy, hodgkin lymphoma, mds (myelodysplastic syndrome), non hodgkin lymphoma